Intuitive Surgical, Inc. $ISRG Stake Lifted by Unio Capital LLC

Unio Capital LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,238 shares of the medical equipment provider’s stock after buying an additional 8,320 shares during the period. Intuitive Surgical makes up 6.5% of Unio Capital LLC’s portfolio, making the stock its 8th biggest position. Unio Capital LLC’s holdings in Intuitive Surgical were worth $30,535,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the stock. Wealth Alliance LLC raised its holdings in shares of Intuitive Surgical by 5.9% during the 1st quarter. Wealth Alliance LLC now owns 2,961 shares of the medical equipment provider’s stock valued at $1,365,000 after buying an additional 166 shares during the period. Unisphere Establishment acquired a new position in Intuitive Surgical during the 1st quarter worth approximately $2,121,000. Sustainable Insight Capital Management LLC lifted its position in Intuitive Surgical by 41.4% during the 1st quarter. Sustainable Insight Capital Management LLC now owns 1,025 shares of the medical equipment provider’s stock worth $473,000 after acquiring an additional 300 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Intuitive Surgical by 4.4% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 127,944 shares of the medical equipment provider’s stock worth $58,981,000 after acquiring an additional 5,370 shares during the period. Finally, Gamco Investors INC. ET AL grew its position in Intuitive Surgical by 10.3% in the first quarter. Gamco Investors INC. ET AL now owns 11,731 shares of the medical equipment provider’s stock valued at $5,408,000 after acquiring an additional 1,096 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical unveiled a five-layer AI framework for its surgical platforms and demonstrated live telesurgical collaboration, signaling that it is embedding AI into clinical workflows and expanding the capabilities of its robotic surgery ecosystem. Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo
• Positive Sentiment: Several analyst-focused pieces framed ISRG as a strong long-term MedTech growth name, highlighting its innovation pipeline, recurring revenue, and high switching costs for surgeons. Why Intuitive Surgical, Inc. (ISRG) is a Top Growth Stock for the Long-Term
• Positive Sentiment: Coverage around Wall Street recommendations continued to describe Intuitive Surgical as a favored investment idea, supporting sentiment around the company’s durable business model. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
• Positive Sentiment: CONMED’s expanded AirSeal indication for da Vinci 5 compatibility may help broaden use across Intuitive Surgical’s platform, reinforcing the ecosystem around its robotic systems. CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
• Neutral Sentiment: Intuitive Surgical remains a frequent subject of analyst and stock-report coverage, but these pieces are mostly commentary rather than new fundamentals, so they are unlikely to move the stock on their own. Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors
• Neutral Sentiment: Short-interest data showed no meaningful change in reported shares, offering little direct signal for investors.
• Negative Sentiment: Some articles emphasized that ISRG’s shares have pulled back sharply and questioned whether growth expectations in its biggest market are changing, which can weigh on sentiment. Intuitive Surgical Stock Is On Sale, But Is the Growth Story Changing?
• Negative Sentiment: J&J’s progress on Ottava was viewed as a reminder that competition in robotic surgery is intensifying, adding pressure to Intuitive Surgical’s market leadership narrative. J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the sale, the director directly owned 239 shares of the company’s stock, valued at $113,156.94. The trade was a 67.66% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock worth $3,059,135 in the last ninety days. 0.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research note on Friday, July 17th. Sanford C. Bernstein lowered their price target on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Piper Sandler reaffirmed an “overweight” rating and set a $470.00 price target (down from $580.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Finally, Evercore set a $430.00 price objective on shares of Intuitive Surgical in a report on Monday, July 6th. Twenty-one research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $523.46.

Intuitive Surgical Trading Up 1.7%

Intuitive Surgical stock opened at $337.50 on Friday. The stock has a market cap of $119.23 billion, a P/E ratio of 38.66, a price-to-earnings-growth ratio of 2.44 and a beta of 1.46. The stock has a 50 day moving average of $406.88 and a 200-day moving average of $459.98. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.81 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.